Synergistic Effect of Posaconazole and Caspofungin against Clinical Zygomycetes
- 1 September 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (9), 3457-3458
- https://doi.org/10.1128/aac.00595-07
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the EtestAntimicrobial Agents and Chemotherapy, 2007
- Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus InfectionAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Interaction of Posaconazole and Caspofungin against Clinical Isolates of Candida glabrataAntimicrobial Agents and Chemotherapy, 2005
- Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic MiceAntimicrobial Agents and Chemotherapy, 2005
- Caspofungin Inhibits Rhizopus oryzae 1,3-β- d -Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated ZygomycosisAntimicrobial Agents and Chemotherapy, 2005
- Combination Treatment of Invasive Fungal InfectionsClinical Microbiology Reviews, 2005
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003
- Eradication of Invasive Mucormycosis--Effectiveness of the Echinocandin FK463Hematology, 2003
- Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2002